CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. - Gimeno L; González-Lozano I; Soto-Ramírez MF; Martínez-Sánchez MV; López-Cubillana P; Fuster JL; Martínez-García J; Martínez-Escribano J; Campillo JA; Pons-Fuster E; Ferri B; López-Abad A; et al. (Oncoimmunology, 2021)